Skip to main content
About
Toggle submenu
About
Our story
Our leaders
Connect
Send a Message
Our Offices
Solutions
Toggle submenu
Solutions
Life Sciences Commercialization
Value & Access
Strategic Consulting
Envision Medical Communications
JAPAC
ProScribe is the most internationally recognized and regionally respected medical communication company in the Asian-Pacific region.
Connect
Send a Message
Our Offices
Technology
Toggle submenu
Technology
Technologies
Industry-leading technology-enabled strategic solutions
EnvisionOne
New, superior-in-class SaaS platform to elevate and synchronize medical information, medical communications, and improve outcomes
iEnvision
Medical affairs workflow platform
EnvisionOne Insights
A unified data & analytics solution for medical affairs
OKRA.ai
Artificial intelligence built for life sciences
4Sight
Holistic AI and technology approach
Connect
Send a Message
Our Offices
News & Events
Careers
Toggle submenu
Careers
Working at Envision
Benefits at Envision
Open Opportunities
Login
Join our Talent Community
FAQs
Connect
Send a Message
Our Offices
social
Toggle submenu
Connect
Send a Message
Our Offices
Connect
Send a Message
Our Offices
Connect
Toggle submenu
Connect
Send a Message
Our Offices
NEWS & EVENTS
Stay informed
about Envision's
news, events, and industry insights
FILTER
- Any -
Appointments
Thought Leadership
Acquisitions
Min
Max
News
Double senior hire at Envision Pharma Group as it bolsters plans for growth and client success in 2025
Jan. 20. 2025
News
Envision Pharma Group partners with Nested Knowledge
Integrating AI-powered evidence synthesis into EnvisionOne technology
Jan. 8. 2025
News
AI adoption guidebook for medical affairs
Co-authored by Jim Streeter, President of Technology, CTO and Yahya Anvar, General Manager and Head of OKRA.ai.
Dec. 17. 2024
News
Envision Pharma Group's OKRA.ai has been named a Gartner® Hype Cycle Sample Vendor in the August 2024 Hype Cycle™ for Life Science Commercial Operations
Nov. 20. 2024
News
Building an AI-enabled medical insights journey with a top 20 pharma client
Oct. 18. 2024
News
Game on: The high stakes and growing pains of bringing cell and gene therapies to market
Contributors: Kyle Felmet, Vice President, Specialty Commercialization and Paul Archer, Chief Commercial Strategy Officer
Oct. 2. 2024
News
Publication bias: The hidden threat to systematic literature reviews
Sep. 26. 2024
Pagination
Previous page
<
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
›